Viking Therapeutics, Inc

VKTXNASDAQ • USD
27.33 USD
↘ 1.89 (6.47%)🟢LIVE (AS OF 12:52 PM EST)
🟢Market: OPEN

Shares of Viking Therapeutics, Inc (VKTX) are trading at $27.33. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". Notable factors include a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place VKTX at a fair price relative to peers.

Technical & fundamental data as of Nov 13, 2026.

Open?$28.56
High?$29.29
Low?$27.25
Prev. Close?$29.22
Volume?1.3M
Avg. Volume?4.8M
VWAP?$27.76
Rel. Volume?0.28x
Bid / Ask
Bid?$27.28 × 100
Ask?$27.46 × 100
Spread?$0.18
Midpoint?$27.37
Valuation & Ratios
Market Cap?3.7B
Shares Out?127.5M
Float?112.1M
Float %?96.1%
P/E Ratio?N/A
P/B Ratio?6.33
EPS?-$4.92
Dividend?0.00%
Ex-Dividend?N/A
RelatedLLYMDGLPFE
News
Profile
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Employees
74
Market Cap
3.7B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2015-04-29
Address
9920 PACIFIC HEIGHTS BLVD, SUITE 500
SAN DIEGO, CA
Phone: 858-704-4660
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
61
Momentum?
50
Short Sent.?
56
Piotroski F-Score?0/9Weak
Altman Z-Score?2.71Grey
Confidence?60%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?21.56%Squeeze Risk
Short Interest?24.2M
Days to Cover?5.4
Free Float112.1M
Avg Daily Volume4.5M
Settlement Date2026-10-30
Financial Health
Current Ratio?7.27Strong
Quick Ratio?7.27Strong
Cash Ratio?5.06Strong
Debt/Equity?0.43Low
ValuationATTRACTIVELY VALUEDvs 3 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
75
S&P
29
6.33FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
-5.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
33
S&P
3
-106.6%WEAK▾
ROA?
Peers
33
S&P
3
-64.2%WEAK▾
Cash Flow & Enterprise
FCF?$-462632000
Enterprise Value?$3.3B
Fundamentals ratios updated end of day